Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 86.28

-0.4%

Feb 9 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Jibacoa	3/1/2016 9:15:48 AM
	of 3722

EXEL up 16% after reporting 4thQ and full year results yesterday and also some news on its deal with Ipsen on further development of its cabozantinib.<g> EXEL will receive a $200 million upfront payment, and up to $545 million of potential commercial milestones and provides for EXEL to receive tiered royalties up to 26% on Ipsen’s net sales of cabozantinib in its territories.<g> finance.yahoo.com The important resistance to watch is the Aug 3 Aug16 double top at the 6.80 level.<g> But before it can do that it has to deal with the Jan25 Feb1 latest double top at the 4.86 level.<g> elite.finviz.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next